Frontiers in Pharmacology, 16, 1516204
A 2021 research review found that once-daily oral semaglutide is as effective, if not more so, for weight loss compared to injectable versions
This happens because the medication addresses a biological driverGLP-1 receptor dysfunctionthat often persists after treatment ends
Yes, we offer Semaglutide-based treatments, including Wegovy, depending on patient eligibility and clinical evaluation
The opportunity is significant given Indias large metabolic disease burden 77 M diabetics (9095% Type-2) and nearly 180M overweight or obese adults
Great results!I combine this with Allmax CLA, and I have been shredding fat like crazy